NAMPT and glioblastoma: Our results suggest that Daporinad-mediated NAMPT inhibition may enhance TMZ sensitivity in GBM, consistent with a recent report demonstrating synergistic effects in both GBM cell lines in vitro [57] and animal models in vivo [62].